Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SCHEDULE – M – Revised

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections

Posted on January 4, 2025 By digi

How to Address Non-Conformities Identified During Schedule M (Revised) Inspections Effective Strategies to Resolve Non-Conformities in Schedule M (Revised) GMP Inspections Introduction to Non-Conformities in GMP Inspections Non-conformities identified during Schedule M (Revised) inspections can significantly impact pharmaceutical manufacturing operations. These findings, which highlight deviations from Good Manufacturing Practices (GMP), pose risks to product quality,…

Read More “How to Address Non-Conformities Identified During Schedule M (Revised) Inspections” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Promotes Drug Safety and Consumer Protection

Posted on January 5, 2025 By digi

How Schedule M (Revised) GMP Promotes Drug Safety and Consumer Protection Ensuring Drug Safety and Consumer Protection Through Schedule M (Revised) GMP Introduction to Drug Safety and Consumer Protection In the pharmaceutical industry, ensuring drug safety is paramount to protecting public health and maintaining consumer trust. Regulatory frameworks like Schedule M (Revised), under the Drugs…

Read More “How Schedule M (Revised) GMP Promotes Drug Safety and Consumer Protection” »

SCHEDULE - M - Revised

The Role of Management in Ensuring Compliance with Schedule M (Revised) GMP

Posted on January 5, 2025 By digi

The Role of Management in Ensuring Compliance with Schedule M (Revised) GMP Management’s Role in Driving Compliance with Schedule M (Revised) GMP Standards Introduction to Management and GMP Compliance Ensuring compliance with Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, requires a proactive and structured approach. While the guidelines outline the technical aspects…

Read More “The Role of Management in Ensuring Compliance with Schedule M (Revised) GMP” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Compliance Affects Pharmaceutical Manufacturing Efficiency

Posted on January 6, 2025 By digi

How Schedule M (Revised) GMP Compliance Affects Pharmaceutical Manufacturing Efficiency The Impact of Schedule M (Revised) GMP Compliance on Pharmaceutical Manufacturing Efficiency Introduction to GMP Compliance and Efficiency In the pharmaceutical industry, efficiency and compliance with regulatory standards are critical for ensuring product quality, safety, and timely market delivery. Schedule M (Revised), under the Drugs…

Read More “How Schedule M (Revised) GMP Compliance Affects Pharmaceutical Manufacturing Efficiency” »

SCHEDULE - M - Revised

How to Prepare for Schedule M (Revised) GMP Audits in Indian Pharmaceutical Manufacturing

Posted on January 7, 2025 By digi

How to Prepare for Schedule M (Revised) GMP Audits in Indian Pharmaceutical Manufacturing Preparing for Schedule M (Revised) GMP Audits in Indian Pharmaceutical Manufacturing Introduction to Schedule M (Revised) GMP Audits Compliance with Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, is critical for Indian pharmaceutical manufacturers to ensure product safety, efficacy, and…

Read More “How to Prepare for Schedule M (Revised) GMP Audits in Indian Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

The Challenges and Benefits of Achieving Schedule M (Revised) GMP Compliance

Posted on January 7, 2025 By digi

The Challenges and Benefits of Achieving Schedule M (Revised) GMP Compliance Exploring the Challenges and Benefits of Schedule M (Revised) GMP Compliance Introduction to Schedule M (Revised) GMP Compliance Compliance with Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, is essential for ensuring the safety, efficacy, and quality of pharmaceutical products in India….

Read More “The Challenges and Benefits of Achieving Schedule M (Revised) GMP Compliance” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Standards Support the Manufacture of High-Risk Drugs

Posted on January 8, 2025 By digi

How Schedule M (Revised) GMP Standards Support the Manufacture of High-Risk Drugs Ensuring Quality and Safety in High-Risk Drug Manufacturing with Schedule M (Revised) GMP Standards Introduction to High-Risk Drugs and GMP Compliance High-risk drugs, including sterile injectables, biologics, cytotoxic drugs, and controlled substances, require stringent manufacturing controls to ensure their safety, efficacy, and quality….

Read More “How Schedule M (Revised) GMP Standards Support the Manufacture of High-Risk Drugs” »

SCHEDULE - M - Revised

How Schedule M (Revised) GMP Promotes Quality Assurance in Pharmaceutical Operations

Posted on January 9, 2025 By digi

How Schedule M (Revised) GMP Promotes Quality Assurance in Pharmaceutical Operations Promoting Quality Assurance in Pharmaceutical Operations with Schedule M (Revised) GMP Introduction to Quality Assurance in Pharmaceutical Manufacturing Quality assurance (QA) is a critical component of pharmaceutical manufacturing, ensuring that products are safe, effective, and compliant with regulatory standards. In India, Schedule M (Revised)…

Read More “How Schedule M (Revised) GMP Promotes Quality Assurance in Pharmaceutical Operations” »

SCHEDULE - M - Revised

Schedule M (Revised) GMP: A Roadmap for Pharmaceutical Manufacturers in India

Posted on January 9, 2025 By digi

Schedule M (Revised) GMP: A Roadmap for Pharmaceutical Manufacturers in India A Roadmap for Pharmaceutical Manufacturers in India: Complying with Schedule M (Revised) GMP Introduction to Schedule M (Revised) GMP In the competitive world of pharmaceutical manufacturing, ensuring product quality, safety, and regulatory compliance is of utmost importance. In India, adherence to Schedule M (Revised)…

Read More “Schedule M (Revised) GMP: A Roadmap for Pharmaceutical Manufacturers in India” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 4 5

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme